| Pediatric and/or Germline Mutation-Associated Myeloid Disorders studied in …STUDIED_INderived10 of 63show all (up to 200) |
|---|
| → studied in | NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05849662Phase 1/Phase 2 · recruiting A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04726241Phase 1/Phase 2 · recruiting The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05702645recruiting A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Myeloid Leukemia Associated with Down Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06247787Phase 1 · recruiting A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy · condition mapped CURATED_BROADER · 63 trials mapped (18 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521493Phase 3 · active not recruiting Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Myeloid Leukemia Associated with Down Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03190915Phase 2 · active not recruiting Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843528Phase 1 · active not recruiting Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03810196NA · recruiting CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03314974Phase 2 · recruiting Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders · condition mapped ONTOLOGY_EXACT · 63 trials mapped (18 active) | — | — | Juvenile Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |